Notably, IFITM3 has also been shown to modulate the tumor microenvironment by promoting CD8+ T-cell infiltration, which is essential for antitumor immunity [43], whereas its deficiency disrupts antigen processing and presentation in cervical cancer cells [44, 45]. Here, CD8A is linked to cervical carcinoma.